Human colorectal tumor cell lines were established which express wildtype p21 or p21 with a mutation at codon 46 (Cys) or 140 (Gly) on IPTG treatment (LacSwitch). The IPTG-induced wildtype p21 bound to CDK2 and PCNA and inhibited CDK activity in the cells and reduced cell growth rate; whereas, both IPTG-induced mutated p21 proteins neither bound to CDK2 nor aected the CDK activity but did bind to PCNA, and they did not aect the cell growth rate. Wildtype p21 suppressed apoptosis and enhanced survival of X-ray-irradiated or adriamycintreated cells; but, mutated p21 neither suppressed apoptosis nor aected cell survival. When cells were treated with mimosine, a p53-independent p21-inducer, or butyrolactone I, a speci®c inhibitor of CDK, cellular endogenous p21 was induced and X-ray or adriamycininduced apoptosis was blocked. These results suggest that CDK-binding or CDK-inhibitory activity of p21 is required to prevent apoptosis, i.e., CDK is required for apoptosis in human tumor cells.
Introduction
Cell cycle progression is driven by the sequential activation of cyclin-dependent kinases (CDKs) and negative eectors, CDK-inhibitory proteins. An important negative eector is p21, also known as Waf1, Cip1 or Sdi1 (Peeper et al., 1994; Harper et al., 1993; Noda et al., 1994; Xiong et al., 1993) , which is regulated transcriptionally by a tumor suppressor gene product p53 (El-Deiry et al., 1993) . It binds to many kinds of CDKs and controls cell cycle progression at the G1 and G2 phases and also binds to the proliferating cell nuclear antigen (PCNA) and inhibits DNA synthesis in vitro (Li et al., 1994; Waga et al., 1994) . Recent ®ndings indicate that CDKbinding or CDK-inhibitory activity occurs in the Nterminal region of p21 and PCNA-binding activity in its C-terminal region (Chen et al., 1995a; Nakanishi et al., 1995b; Zakut and Givol, 1995) .
Eector p21 functions to arrest the cell cycle at the G1 checkpoint after treatment of cells with DNAdamaging agents. When normal cells suer DNA damage, their p53 contents are enhanced. Subsequently, p21 and the apoptosis-inducing proteins Bax, Fas and IGF-BP3 are induced. The cell cycle then is arrested at the G1 phase or apoptotic cell suicide is triggered (Polyak et al., 1996; Waldman et al., 1995) . p21 also is induced through a p53-independent pathway, when cell growth is arrested by chemicals such as mimosine or okadaic acid (Alpan and Pardee, 1996) , or during cellular dierentiation and senescence (Noda et al., 1994) .
p21 is thought to be required for the induction of apoptosis in some cells (El-Deiry et al., 1994) , but cells derived from the p21-knockout mouse still undergo apoptosis following X-ray irradiation (Deng et al., 1995) . Recent ®ndings, however, have shown that an increase in p21 blocks cell growth and inhibits apoptosis (Gorospe et al., 1996 (Gorospe et al., , 1997 Attard et al., 1996) .
We previously reported that u.v. light irradiation of p21 cDNA induced mutations and led to inhibition of the growth-arresting activity of p21 (Lu et al., 1996) . Mutations predominantly occurred at codon 46 in the CDK-binding or CDK-inhibitory region. We have established human colorectal tumor cell lines in which the wildtype or two mutated p21 cDNA that have an amino acid substitution at codon 46 or 140 can be expressed by the use of isopropyl-b-D-thiogalactopyranoside (IPTG). We show that both mutated p21 proteins lack the ability to inhibit CDK2 activity and that adriamycin-or X-ray-induced apoptotic cell death is prevented by wildtype p21 expression but not by mutated p21 expression. Our ®ndings suggest that the CDK-inhibitory activity of p21 is required to prevent apoptosis in human tumor cells.
Results

Inducible expression of p21 by LacSwitch
We established three kinds of human colorectal tumor cell lines in which wildtype p21 or p21 with a mutation at codon 46 or 140 can be expressed in IPTGcontaining medium by the LacSwitch promoter system and also established a control cell line with a vector plasmid. These cell lines have been named DLD-wtp21, DLD-mtp21 46Cys , DLD-mtp21 140Gly and DLD-vector. Induction of p21 expression in the DLD-wtp21, and DLD-mtp21 46Cys , DLD-mtp21 140Gly cells on treatment with IPTG for 24 h was detected by Western blotting with an anti-p21 antibody (Figure 1 ). p21 was induced 15-, 10-and 15-fold, respectively, in the DLD-wtp21, DLD-mtp21 46Cys and DLD-mtp21 140Gly cells by IPTG, as compared to the control values. As DLD-1 cells have a mutation in the p53 gene (Rodrigues et al., 1990) , no p21 induction was detected after u.v. or X-ray irradiation (data not shown). Figure 2 shows the growth curves of these cell lines in medium with and without IPTG. The growth rate of the DLDwtp21 cells was reduced by IPTG, whereas the rates of the DLD-mtp21 46Cys , DLD-mtp21 140Gly and DLD-vector cells were not aected. These results show that the expression of wildtype p21 suppresses cell proliferation, whereas that of the two kinds of mutated p21 does not.
To examine the change in the cell cycle pattern after expression of the wildtype p21 or mutated p21, thē ow cytometry was carried out (Figure 3) . In DLDwtp21 cells, a fraction of G1-phase cells was increased from 48 to 59% by IPTG, indicating that the cell cycle is partially arrested at G1-phase and the growth retardation by the wildtype p21 is due to the partial G1 arrest. In DLD-mtp21 46Cys and DLD-mtp21 140Gly cells, the cell cycle pattern was not aected by IPTG.
Mutated p21 is unable to bind to CDK2 and to aect CDK2 activity but binds to PCNA
To examine whether the wildtype and mutated p21s can bind to CDK2 and PCNA, proteins co-immunoprecipitated with p21 by an anti-p21 antibody in extracts of IPTG-treated DLD-wtp21, DLD-mtp21 46Cys and DLD-mtp21 140Gly were separated by SDS-polyacrylamide gel electrophoresis, and the presence of CDK2 and PCNA in the immunoprecipitates was examined by Western blot analysis with anti-CDK2 and anti-PCNA antibodies, respectively (Figure 1 ). Both CDK2 and PCNA were co-immunoprecipitated with the wildtype p21 in the DLD-wtp21 cell extract, indicative that the wildtype p21 induced by IPTG binds to both CDK2 and PCNA in vivo. The p21 with a mutation at codon 46 in the CDK-binding domain bound to a ®vefold less amount of CDK2 than the wildtype p21, but it bound to almost the same amount of PCNA as the wildtype p21. A similar result was obtained for p21 with a mutation at codon 140 close to the PCNAbinding domain. It bound to eightfold less the amount of CDK2 than did the wildtype p21, but it bound to PCNA as much as did the wildtype p21. To examine whether the wildtype and mutated p21s can alter the CDK2 kinase activity in vivo, cell extracts were immunoprecipitated with an antibody against CDK2 and then CDK2 kinase activity was measured by using histone H1 as a phosphorylation substrate. The wildtype p21 substantially inhibited CDK2 activity in vivo in accordance with its tight binding to CDK2 (Figure 1 ). However, no decrease in the CDK2 kinase activity by IPTG was observed in DLD-mtp21 46Cys and DLD-mtp21 140Gly cells.
Cell survival after X-ray irradiation or adriamycin treatment is enhanced by wildtype p21 expression but not by mutated p21 expression
Cell survival after ADR treatment or X-ray irradiation in the presence or absence of IPTG is shown in Figures  4 and 5. When DLD-wtp21 cells were exposed to ADR or X-rays, their survival was enhanced by IPTG treatment. In contrast, when DLD-mtp21 46Cys , DLDmtp21 140Gly and DLD-vector cells were exposed to ADR or X-rays, their survival was not aected by IPTG treatment. These results indicate that the wildtype p21 induced by IPTG treatment prevents X-ray nor ADRcaused cell death. A more marked eect of wildtype p21 against cell death was occurred in ADR-treated than in X-ray-irradiated cells.
Adriamycin or X-ray-induced apoptosis is prevented by wildtype but not mutated p21
To determine whether the cell death caused by ADR or X-rays was due to apoptosis, the nuclear morphology of the cells was examined by staining them with the DNA-binding dye Hoechst 33258 and by microscopy ( Figure 6a ). DNA fragmentation in the cells was examined by agarose gel electrophoresis (Figure 6b) .
After 3 h of treatment with ADR in the presence of IPTG, or after X-ray irradiation followed by incubation with IPTG for 24 h, more than 90% of the DLDwtp21 cells showed normal morphology. In the absence of IPTG, a large fraction of cells that had fragmented and lobular nuclei, typical apoptotic morphology, was found. In contrast, DLD-mtp21 46Cys , DLD-mtp21 140Gly and DLD-vector cells showed this typical apoptotic morphology after ADR or X-ray treatment whether or not IPTG was present (data not shown).
Agarose gel electrophoresis detected DNA fragmentation in all the cells after ADR treatment with X-ray irradiation (Figure 6b ). In the DLD-wtp21 cells, ADRor X-ray-induced fragmentation was greatly suppressed by IPTG treatment. In the DLD-mtp21 46Cys , DLDmtp21 140Gly and DLD-vector cells, fragmentation was not suppressed by IPTG treatment. Figure 7 shows the increase in the apoptotic cell fraction with time after ADR or X-ray treatment. More than 40% of the DLD-mtp21 46Cys , DLDmtp21 140Gly and DLD-vector cells underwent apoptosis 3 days after 3 h incubation with ADR or after X-ray irradiation in the presence or absence of IPTG. DLDwtp21 cells also underwent apoptosis in the absence of IPTG, but the apoptotic cell fraction was strikingly reduced in the presence of IPTG.
These results clearly show that the apoptosis of cells with DNA damage is prevented by the expression of wildtype p21 but not by the expression of its two mutations. Adriamycin-or X-ray-induced apoptosis is prevented by butyrolactone I and mimosine Because p21 expression by the LacSwitch is an extrinsic system, we examined whether ADR-or X-ray-induced apoptosis was prevented by the p21 expressed from the endogenous p21 gene. When DLD-1 cells were treated with mimosine, a DNA polymerase inhibitor and a p53-independent p21-inducer (Alpan and Pardee, 1996) , concomitantly with ADR or after X-ray irradiation, the apoptotic cell fraction was markedly reduced (10 and 15%) as compared to the fraction (40 and 64%) without mimosine treatment (Figure 8c and d) .
If the prevention of apoptosis is due to the CDKinhibitory activity of p21, butyrolactone I, a speci®c inhibitor of CDKs (Kitagawa et al., 1993) , should inhibit apoptosis. When DLD-1 cells were treated with butyrolactone I concomitantly with ADR or after Xray irradiation, the apoptotic cell fraction was strikingly reduced (7 and 9%) as compared to the fraction (42 and 68%) without butyrolactone I treatment (Figure 8) .
These results unamibiguously support the idea that the CDK-binding or CDK-inhibitory activity of p21 is required to prevent ADR-or X-ray-induced apoptosis.
Discussion
We established three human colorectal tumor cell lines in which wildtype p21 or p21 with a mutation at codon 46 (Arg to Cys) or 140 (Arg to Gly) can be expressed by IPTG treatment. Because codon 46 is located in the CDK-inhibitory or CDK-binding region (Goubin and Ducommun, 1995) , p21 46Cys can neither bind to CDK2 nor aect CDK2 activity, but it does bind to PCNA as expected. Although codon 140 is located in the Cterminal region far from the CDK-inhibitory domain and close to the PCNA-binding domain, (Nakanishi et al., 1995b), p21 140Gly also can neither bind to CDK2 nor aect CDK2 activity, but it does bind to PCNA. These ®ndings are consistent with those of recent studies showing that p21 with mutations in the PCNA-binding region can not inhibit CDK2 (Balbin et al., 1996; Adams et al., 1996) . The mutations in this region may aect the overall structure of p21 rather than change its speci®c CDK-binding site.
Early reports (Chen et al., 1995a) showed that the wildtype p21 binds to various cyclin/CDK complexes and inhibits their phosphorylation activity. One of their major phosphorylation targets is RB protein, which proceeds the cell cycle from G1 to S phase. We demonstrated that the wildtype p21 binds to CDK2 and inhibits the CDK2 kinase activity and arrests the cell cycle at the G1 phase, but substitution of the amino acids in p21 abolished its CDK2-binding and CDK2-inhibitory activities and strikingly decreased its suppressing eect on cell proliferation. In a cell-free DNA replication assay, the inhibition of DNA synthesis by the p21 was thought to be due to its binding to PCNA, a processivity factor of DNA polymerase d and e . Our ®ndings suggest that the inhibition of DNA synthesis by p21 in vivo is due to inhibition of its CDK activity and subsequent RB inactivation rather than to its binding to PCNA. The p21 mutant that binds to CDK but not to PCNA should be required to verify it unequivocally.
We observed that wildtype p21-mediated growth arrest is characterized by an increase in G1-phase cells, a b Figure 7 Time-dependent increase in apoptotic cell fractions. Cells cultured in medium with (5 mM) or without IPTG after 3 h adriamycin treatment (2 mg/ml) (a), or cultured after X-ray irradiation (14 Gy) (b), were stained with Hoechst 33258. Apoptotic cells were counted under a microscope a b c d Figure 8 Suppression of apoptosis by butyrolactone I or mimosine. DLD-1 cells were cultured with (50 mM) or without butyrolactone I after 3 h adriamycin treatment (2 mg/ml) (a), or cultured after X-ray irradiation (14 Gy) (b). DLD-1 cells were cultured with (300 mM) or without mimosine after 3 h adriamycin treatment (2 mg/ml) (c), or cultured after X-ray irradiation (14 Gy) (d) and mimosine or butyrolactone I induces endogenous p21 in DLD-1 cells (data not shown). Our results suggest that inhibition of CDK activity by p21 is required for G1-phase arrest and the G1-phase arrest is required for prevention of ADR-or X-ray-induced apoptosis probably because DNA repair would be carried out during the G1-phase (MacDonald et al., 1996; Fan et al., 1997) . p21 is thought to be a potential tumor suppressor gene because the other CDK-inhibiting genes, p15 and p16, often are mutated in human tumors; whereas, only a few p21 mutations have been reported (Bhatia et al., 1995; Balbin et al., 1996; Li et al., 1995) . All the p21 mutants induced by u.v. in our previous study, including p21 46Cys and p21 140Gly , were considered to lack the ability to inhibit apoptosis because all lost their growth-inhibitory activity (Lu et al., 1996) . This suggests that cells with the wildtype p21 would survive whereas those with a mutation in the p21 gene would be eliminated by apoptotic cell death when they suer DNA damage. This is a reasonable explanation of why p21 gene mutations are rare in human tumors. p21 is activated transcriptionally by the wildtype but not mutated p53. Human cells carrying the wildtype p53 generally are accepted as being more sensitive to X-ray irradiation than cells with mutated p53; but, our ®ndings show that the expression of p21 enhanced cell survival of X-rays. Chen et al. (1996) reported that apoptotic cell death is enhanced but the expression level of p21 remains constant with an increase in p53 expression. G1 arrest at a low p53 content and apoptosis at a high content also have been reported (Chen et al., 1996; Lassus et al., 1996; Ludwig et al., 1996) . Taking into account these reports and our ®ndings, enhancement of cell survival by p21 and of cell death by the apoptosis-causing genes Bax, Fas and IGF-BP3 may operate antagonistically under the control of p53 in damaged cells. This hypothesis is supported by our other ®nding that the expression of endogenous p21 by mimosine inhibited ADR-and Xray-induced apoptotic cell death.
Suppression of apoptosis due to the expression of p21 has recently been reported (Wang and Walsh., 1996; Gorospe et al., 1996 Gorospe et al., , 1997 Waldman et al., 1996; Attard et al., 1996) . From our ®ndings, we can conclude that CDK-binding or CDK-inhibiting activity of p21 is required to suppress apoptotic cell death and the cells with the mutated p21 lacking the CDKbinding or CDK-inhibiting activity undergo apoptosis. However, further studies should be extended to solidify the conclusion because other possible mechanisms for inhibition of apoptosis by p21 still remain. For example, inhibition of apoptosis by the mutated CDK that lacks phosphorylation activity should be examined. Role of the CDK-independent action of p21, that is inhibition of stress-activated MAP kinase JNK (SAPK) and p38 (Shim et al., 1996; Seimiya et al., 1997) , on apoptosis should also be investigated.
Materials and methods
Establishment of human colorectal tumor cell lines that can express p21 by the LacSwitch
To control the expression of exogenous p21, we used the LacSwitch-inducible mammalian expression system (Stratagene, La Jolla, CA). DLD-1 cells, derived from a human colorectal carcinoma, which has a p53 gene mutation, were transfected by electroporation with p3'SS plasmids containing the lac-repressor (lacI) and hygromycin-resistant genes. The cells then were selected by culturing them with hygromycin B (300 mg/ml) for 2 weeks. A cell clone expressing lacI protein (con®rmed by Western blotting) next was transfected with the p21 expression plasmids driven by a Rous sarcoma virus-long terminal repeat promoter containing the lac operator. The p21 expression plasmids were constructed as follows. Human wildtype p21 cDNA derived from pcDSRa SDI1 (supplied by Dr Noda), p21 cDNAs with a point mutation from CGT (Arg) to TGT (Cys) at codon 46 in the CDK-binding or CDKinhibitory domain, or with a point mutation from CGA (Arg) to GGA (Gly) at codon 140 close to the PCNAbinding domain, obtained from ultraviolet (u.v.) lightirradiated mutants (Lu et al., 1996) , were cloned into the NotI site of pOPRSV1 plasmids carrying a neomycinresistant gene. The expression plasmids were named pOPRSVIwtp21, pOPRSVImtp21Cys 46 and pOPRSVImtp21Gly 140 . Mutations were con®rmed by digestion with the restriction enzymes StuI or TaqI which respectively recognize the mutated sequences of codons 46 or 140. After transfection with these plasmids, cells were selected with geneticin (400 mg/ml). Their clones were isolated and maintained at 378C in 95% air and 5% CO 2 in Dulbecco's modi®ed Eagle's minimum essential medium (Nikken, Kyoto, Japan) supplemented with 10% fetal bovine serum (Hyclone, Logan, UT), hygromycin B (300 mg/ml) and geneticin (400 mg/ml). p21 expression in these clones was induced in growth medium containing 5 mM isopropyl-b-D-thiogalactopyranoside (IPTG).
Western blotting and immunoprecipitation
At 90% con¯uence the cell monolayer was washed with phosphate-buered saline (PBS) and lysed at 48C for 10 min in buer consisting of 10 mM Tris-HCl, 150 mM NaCl, 5 mM EDTA, 1% NP40, 1% trasylol and 0.2 ng/ml phenylmethylsulfonyl¯uoride (PMSF) (Sigma, St Louis, MO). Cellular debris was removed by centrifugation, and the protein content of the cell lysate was determined by the Bradford calorimetric assay method (Biorad, Richmond, CA). A 40 mg aliquot of the cell lysate was resolved by 16% polyacrylamide-SDS gel electrophoresis and transferred to a Hybond-C Super membrane (Amersham, UK). p21 protein was detected with an anti-p21 antibody (SC-187, Santa Cruz Biotechnology, Santa Cruz, CA) and horse radish peroxidase (HRP)-conjugated protein A using a Renaissance Chemiluminescence kit (Dupont, Boston, MA).
For immunoprecipitation, a 1 mg aliquot of the cellular lysate was incubated for 1 h at 48C with 5 ml of the anti-p21 antibody (SC-187). Immune complexes were captured by incubation with 80 ml protein G-plus-agarose (Santa Cruz Biotechnology, Santa Cruz, CA) for 1 h, then washed several times with the lysis buer. Co-immunoprecipitated proteins were separated by 16% polyacrylamide-SDS gel electrophoresis and transferred to a Hybond-C Super membrane. PCNA and CDK2 were detected, respectively, with an anti-PCNA antibody (PC10, Santa Cruz Biotechnology, Santa Cruz, CA) and an anti-CDK2 antibody (SC-163, Santa Cruz Biotechnology, Santa Cruz, CA) and with HRP-conjugated protein A using a Renaissance Chemiluminescence kit (Dupont, Boston, MA).
CDK2 kinase assay
Cell extracts (100 mg) were incubated with an anti-CDK2 antibody (SC-163), and the complexes were collected with 80 ml protein G-plus-agarose (Santa Cruz Biotechnology, Santa Cruz, CA). The cyclin-dependent kinase activity was measured by the CDK assay kit (Upstate Biotechnology, Lake Placid, NY). Brie¯y, the immune complexes (40 mg) were mixed with [g-32 P]ATP (3000 Ci/mmol), histone H1 (2 mg) as a substrate and the reaction buer containing inhibitors of other kinases. After incubation for 10 min at 308C, phosphorylated histone H1 was resolved by 16% polyacrylamide-SDS gel electrophoresis and detected by autoradiography.
Cell growth analysis
To examine the growth rate, cells were seeded in 60 mm dishes (5610 4 cells/dish) containing medium with or without 5 mM IPTG. The medium was changed every other day, and the number of cells counted daily.
Cell cycle analysis
Cells were washed twice with PBS, trypsinized and resuspended in PBS containing 0.1% Triton X-100 and RNase (1 mg/ml) (Sigma, St Louis, MO). The cell suspension was incubated at 378C for 30 min. Propidium iodide (Molecular Probes, Inc. Eugene, OR) was added at a ®nal concentration of 50 mg/ml and the cell suspension was kept at 48C for 1 h. The cells were ®ltered through 50 mm nylon mesh, and the cell cycle was analysed by¯ow cytometry with the FACScan system (Becton Dickinson, Franklin Lakes, NJ).
Cell survival after adriamycin treatment or X-ray irradiation
Details of the method were reported by Chen et al. (1995b) . In brief, exponentially growing cells were trypsinized, serially diluted, plated in 60 mm dishes then incubated in medium supplemented with 5 mM IPTG for 16 h. After X-ray irradiation or ADR treatment for 3 h in the presence of IPTG, the cells were cultured in medium with IPTG for 24 h then washed with PBS and further cultured in normal medium for 2 weeks. In the control, no IPTG was added to the culture medium. Colonies were stained with crystal violet and scored.
Observation of apoptotic cells after adriamycin treatment or Xray irradiation Cells were cultured with ADR (2 mg/ml) or after X-ray irradiation in medium containing IPTG (5 mM), mimosine (300 mM) or butyrolactone 1 (50 mM). They then were washed with PBS, stained with the DNA-binding dye, Hoechst 33258 (0.5 mg/ml in PBS), and observed under a¯uorescence microscope. Cells showing condensed nuclear morphology and nuclear lobulations were regarded as apoptotic.
DNA fragmentation in cells after adriamycin treatment or Xray irradiation
Cells were cultured in the presence of ADR (2 mg/ml) or after X-ray irradiation (14 Gy) in medium with or without IPTG (5 mM). DNA extracted using an Apoptosis Ladder Detection Kit (Wako, Osaka, Japan), was separated by agarose gel electrophoresis and stained with SYBR Green I (Molecular Probes, Eugene, OR).
